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Redesigning and Incorporating the EpiPen into a
Smartphone Case
Kayvon Ghoreshi
Dr. Donald Peterson

Abstract
In the event of anaphylaxis, people need an immediate injection of epinephrine. The
EpiPen has provided such injections, but its size can make it somewhat unwieldy for people to
carry around. This leads to many people simply not having it with them. The aim of this project
is to design an epinephrine auto-injector that is more portable by integrating it into a
smartphone case. While the EpiPen uses a spring mechanism, other options such as gas were
explored. After testing, it was clear that a gas cartridge could supply sufficient power for
injection. In the proposed design, using a gas cartridge helped minimize the size of the device
and enabled the needle to be retracted after injection. The design is not only smaller than the
current EpiPen, but is also able to be carried with an iPhone case.
1. Background
People with allergies face the potentially deadly threat of anaphylaxis, a severe allergic
reaction that can occur within seconds of being exposed to an allergen, which commonly
includes things like peanuts or the venom of a bee sting. The flood of chemicals from the
immune system in response to the allergen can lead to shock as well as a drop in blood
pressure and a narrowing of airways which hinders breathing (Mayo Clinic, 2013). Victims
require immediate attention at an emergency room as well as an injection of epinephrine. This
need for a shot of epinephrine led to the creation of epinephrine auto-injectors, the most
prominent of which is the EpiPen. The device delivers two different dosages: 0.15mg of
epinephrine for children and 0.30mg for adults. While the EpiPen has enjoyed over 95% market
share among epinephrine auto-injectors (Goldenberg, 2013), it still has shortcomings that can
be improved upon.

One common complaint about the EpiPen is its size. When encased, the device
measures out to about 6 inches in length, which can make it uncomfortable to carry. In turn,
some people simply choose to not have an EpiPen on their person even though it is
recommended that the EpiPen should be available at all times. According to a survey from
Sanofi (PR Newswire, 2013), nearly two-thirds of patients and caregivers do not carry their
EpiPens as recommended. In addition to the EpiPen being left behind, due to ergonomic
factors, general forgetfulness, or other reasons, there is also an issue of usability. In another
survey done by Sanofi, nearly half worry that others will not know how to use their, or their
child's, epinephrine auto-injector correctly during an emergency. While most medical
professionals and EpiPen carriers know how to use the device, there are plenty of people who
are unfamiliar with the device and even use it incorrectly. A study by Nguyen (2012) showed
ineptitude of school staff in using EpiPens. Among personnel in elementary schools, the
majority of which were teachers and lunch aids, only 23.7% were able to use the EpiPen
properly, which is incredibly poor given that 89.2% of participants reported prior training in
using an EpiPen. These results are particularly worrying because in the case with elementary
school children, many may not be able to use an EpiPen themselves and thus rely on teachers
and staff to be able to perform the injection. While this does show the need for a more intuitive
epinephrine auto-injector, it also points to other necessary factors for an effective device, such
as proper training.
1.1 Understanding Injection Mechanisms
In order to design a new epinephrine auto-injector, it was necessary to understand how
the devices currently on the market worked and what areas could be improved upon. The two

chosen devices were the EpiPen and the most recent device, the Auvi-Q. Multiple EpiPens were
taken apart in order to understand the mechanics of the device in addition to information
provided by the patent. An Auvi-Q could not be acquired, so only the patent was available for
understanding the mechanism.
The EpiPen works with a spring loaded mechanism. A compressed spring is coiled
around the plunger and held in place by the slightly wider top of the plunger. The top of the
plunger has a hollowed opening that houses the blue safety cap. When activating the device,
the blue safety cap is removed. The needle end of the EpiPen is then pushed against the
person’s outer thigh, which pushes the contents of the device upward. This pushes the plunger
upward into a narrower hole, causing the top to squeeze in. By squeezing the top of the
plunger, the spring is released and allowed to expand. This pushes the plunger downwards,
forcing the needle through its cover and into the person’s leg and pushing the fluid out of the
vial. As the vial is pushed down, it releases two locking teeth represented as number 340 in
Figure 2. This releases a spring in the needle end of the device, expanding the orange sheath,
seen in Figure 1, to cover the needle.

Figure 1: EpiPen Taken Apart

Figure 2: EpiPen Patent Drawing (Young, 2008)
The Auvi-Q is the latest epinephrine auto-injector and competitor to the EpiPen. Unlike
the cylindrical design of the current EpiPen, it is shaped more like a smartphone. The Auvi-Q is
also smaller than the current EpiPen, coming in at 3.5 inches tall, 2 inches wide and a half inch
thick. In addition to shape, another major difference from the EpiPen is that the injection from
an Auvi-Q is powered by gas rather than a spring. The device is still activated by the release of a
spring, but this spring (part 3560 in Figure 3) pushes an azide gas container (part 3412) into a

puncturing mechanism (part 3612). The gas is released and this force pushes down the plunger
and the needle, injecting the epinephrine fluid. After the injection, the gas is released from the
device and the springs on either side of the needle expand, retracting the needle.

Figure 3: Auvi-Q Patent Drawing (Edwards, 2011)
1.2 Parts of the EpiPen
The EpiPen has two springs: the spring around the plunger and the spring that pushes
out the needle sheath. The springs measure 4.625 and 3 inches in length, respectively. Both
springs were hung from a ladder and then had different weights attached to them. The spring
extensions were recorded to calculate each spring’s spring constant using Hooke’s law. The
larger spring (part number 530 in Figure 2) was measured with standard 2.5, 5, 7.5, and 10
pound weights, respectively. The smaller spring (part number 153 in Figure 2), on the other

hand, was too weak to handle the larger weights and thus required other objects around the
lab that were first weighed in grams and then converted to pounds. These weights came out to
.19287, .33069, .64375, and 1.12877 pounds, respectively. A linear regression was used for
both sets of data in order to find the spring constants. The larger spring that provided the
power for the injection had a calculated spring constant of 8.6466 lbs/in, which falls into the
ballpark of a similar Duke study (Addison, 2006) that concluded that the spring constant for the
bigger spring was between 8 and 10 lbs/in. The spring constant for the smaller sheath spring
came out to 0.6266 lbs/in, although no other study was found to confirm it.
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Figure 4: Spring Constants and Linear Regressions of EpiPen Springs
Some of the other major parts of the EpiPen that will likely need to be included in a new
device include the vial, the needle, and the plunger. The vial, made of borosilicate glass, is
approximately 4.5cm in length with an inside diameter of 9mm and a wall thickness of about
1mm. It has a cross sectional area of about .636cm² and a volume of around 3mL. The needle

used for injection in the EpiPen is a 7/8in, stainless steel 22 gauge needle, and it is covered by a
sheath to protect it from damage and to keep it sterile.
1.3 Cell Phone Case
One of the main goals of this project was to design an epinephrine auto-injector that
could be incorporated into a cell phone case. This would make it easier for someone to have it
on their person at all times. As an example, the iPhone 5 measures 2.31in x 4.87in x 0.3in as a
standalone device. Some original design ideas incorporated the injection mechanism on the
back of the phone, using a flatter elliptical-shaped vial and plunger; however, there were
concerns of the mechanism making the case too thick. In one proposed design, the device rests
on the side of the iPhone, adding width to the phone rather than depth.
1.4 Gas Cartridges
In the interest of minimizing size and being able to retract the needle, it was decided
that a gas cartridge should be used as the main power source for injection. The cartridges
tested for the device were two mini gas cartridges (models 40106 and 40106IN21750, Leland
Limited Inc., South Plainfield, NJ). Both cartridges had nearly identical dimensions and
measured only one inch in length, as seen in Figure 5, which is ideal for a device that is trying to
minimize size. The two cartridges came filled with different gases at different pressures: one
was filled with carbon dioxide at 850 psi and the other was filled with nitrogen gas at 1750 psi.
Figure 5 shows a model of one of the gas cartridges.

Figure 5: Mini Gas Cartridge (Leland Limited Inc., Model 40106IN21750
2. Methods

Various makeshift puncture devices were made to puncture the gas cartridges as the
manufacturer did not offer any puncture devices for their mini cartridges. In order to see how
the cartridges reacted when punctured, they were first held by a clamp and then punctured
with a hammer and nail as seen in Figure 6. Both cartridges showed a nearly instantaneous
release of gas, with the nitrogen-filled cartridge feeling a little more forceful, likely due to the
higher pressure.

Figure 6: Initial Gas Cartridge Puncture

The next puncture device used was a modified syringe, as seen in Figure 7, with one
end soldered close in order to create an airtight environment. A nail was soldered into the
plunger and seal to act as the puncturing mechanism. Within the syringe there was a
containment unit for the gas cartridge. Using a 3-D printer (Replicator 2X, Makerbot Industries,
LLC, Brooklyn, NY), two cylinders were printed to form the containment unit. One held the
cartridge in place and prevented it from wobbling, while the other covered the top with 5 holes
as seen in Figure 8.

Figure 7: Modified Syringe Used to Puncture Gas Cartridges

Figure 8: Gas Cartridge Container
The gas cartridge was placed in the containment unit with the puncture region facing
the holes. The center hole lined up the nail with the puncture region, while the surrounding
holes were used for expelling gas. In testing, the syringe was held in place by a clamp with the
soldered end pointing downwards. The plunger was tapped downward in order to puncture the
gas cartridge. Both the carbon dioxide and nitrogen-filled cartridge were able to expel the
plunger, although it appeared the nitrogen-filled cartridge did so with much more force.

It was also necessary to get the force needed to puncture a gas cartridge. A strain gauge
load cell (MLP-200, Transducer Techniques, Rio Nedo Temecula, CA) was used to measure
force, while a data acquisition and analysis system (MP100 and AcqKnowledge v3.5.1, Biopac
Systems Inc., Goleta, CA) collected the data. A custom screw was printed with the 3-D printer to
fit into the load cell and to hold the gas cartridge in place. A piece of tape was wrapped around
the gas cartridge to get a tighter fit so there would be no wobbling. In order to puncture the
cartridges, a press head was also printed and used to hold the nail in place. The experiment
setup can be seen in Figure 9.

Figure 9: Setup for Testing Puncture Force
Prior to data collection, it was necessary to find a relationship (i.e. calibration) between
volts and pounds of force for the load cell since data would be recorded in volts. To do so,
varying known weights were placed on the sensor in a randomized order. This would give a
reading of volts which was recorded and served as the calibration for the sensor. This data was
put into a scatter plot and then put through a linear regression to find the relationship between

volts and pounds, as seen in Figure 10, which was then applied to the recorded data to convert
volts into pounds of force.
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Figure 10: Linear Regression of Relationship Between Pounds and Volts (i.e. Sensor
Calibration Curve)
Results and Proposed Design
Two cartridges of each gas were used to test puncture force. In order to account for the
nearly simultaneous moment between puncture and gas release, 50,000 samples were
collected per second. In each test, the nail was lowered and then left in the cartridge after it
was punctured. Figure 11 shows the result of the carbon dioxide cartridges, and while both
have similar peaks in force, the differences in gas flow are likely due to inconsistencies in how
the cartridges were punctured. The graph for the nitrogen cartridges, shown in Figure 12,
shows more consistency in puncturing as both cartridges have a similar pattern of inclines and
drops in force. In both graphs, the red line has been adjusted to line up with the other data.

Figure 11: Carbon Dioxide Cartridges; X-Axis is Seconds, Y-Axis is Pounds of Force; Black Line
is First Cartridge, Red Line is Second Cartridge

Figure 12: Nitrogen Cartridges; X-Axis is Seconds, Y-Axis is Pounds of Force; Black Line is First
Cartridge, Red Line is Second Cartridge
Within the data, the two main points of interest were the point of puncture and peak
thrust force from the cartridge. As far as peak thrust force, the two types of cartridges appear
to be nearly identical with the carbon dioxide cartridges reaching roughly 20 pounds of force
and nitrogen cartridges peaking around 23 pounds. These can be considered the base amount
of force, although it would likely increase if the gas were to expand in an enclosed device as
opposed to open air.
In order to pinpoint the puncture force, it was necessary to look at the start of each
graph. The initial dips to zero, seen clearly in Figure 13, mark the moments where the nail has
punctured the cartridge, meaning the cartridge is no longer pushing against the load cell, and
the gas has not yet released to create a thrust force. This means that the force reading right
before the dip should be the puncture force. For the carbon dioxide cartridges, Figure 11, the

reading was somewhat unclear, although it appeared to be close to 14 pounds. However, this is
unlikely given the minimal force that was used in previous puncturing with the modified syringe
and the hammer and nail. The data from the nitrogen cartridges, Figure 13, shows the puncture
force to be less than 3 pounds, which is much more in line with the force used in previous tests.

Figure 13: Nitrogen Cartridges; X-Axis is Milliseconds, Y-Axis is Pounds of Force; Black Line is
First Cartridge, Red Line is Second Cartridge

3.1 Proposed Design
In the proposed design, shown in Figure 14, the epinephrine auto-injector rests in a
cylindrical body. The vial and needle components remain unchanged from the current EpiPen,
but the plunger has been redesigned, as seen in Figure 16. Although the seal for the vial
remains unchanged, the plunger is now designed to hold a gas cartridge rather than a spring.

There is also a spring at the needle end of the device to retract the needle after injection. All of
these parts connect together and are put in a cylindrical body that is narrower on the needle
end. This body is the put in a larger enclosure, which has a puncture tip lined up with the gas
cartridge. The proposed design would be roughly 4.7 inches in length as opposed to the current
EpiPen which is around 6 inches. The device could also be able to be attached to an iPhone case
as in Figure 15 which is designed for the iPhone 5.
In the event of anaphylaxis, the needle end of the device would be pushed against a
person’s outer thigh. This should push the inside cylinder upwards, causing the gas cartridge to
be punctured and releasing the gas. The thrust force combined with the expansion of the gas
should create a downward force that compresses the spring, injects the needle, and pushes out
the epinephrine solution. Once the injection has completed, the gas can be released from the
device, which allows the spring to expand and retract the needle.

Figure 14: Proposed Design for Epinephrine Auto-Injector

Figure 15: Proposed Design to Hold Injection Pen in iPhone 5 Case

Figure 16: Plunger for Proposed Design
4. Discussion
Two necessary additions to the proposed design are a safety mechanism and an easier
way for gas to escape once the injection is complete. The current design offers no safety
mechanism. One possibility is a cap for the needle end of the device. This would prevent the
inner cylinder from being pushed upward, thus preventing the cartridge from being punctured.
Either a hole on the side of the device or a removable latch could be used as a means to
exhaust the gas more effectively after the injection is complete. Another possible design option
is to have the spring in Figure 14 already in a compressed state. The safety could hold this
spring in a compressed state, and once released it will expand, push up the contents of the
device, and puncture the cartridge. Since the force from the gas cartridge is greater than the
necessary puncture force, the spring can still be recompressed and expanded to retract the
needle as originally proposed.
There also needs to be further testing on the gas cartridges. Inconsistencies in the data
were likely due to human error as there were likely slight differences in the way each cartridge
was punctured. This can be remedied in future testing with an automated method of

puncturing and with more samples so as to have more comparable data. Gas cartridges also
need to be tested while in an enclosed environment similar to the proposed device as opposed
to the initial tests which were in open air.
5. Conclusion
The proposed design is still in its early stages. In addition to adjustments, a prototype
needs to be constructed in order to test the puncturing, injecting, and retracting phases of the
proposed mechanism to see how its performance compares to devices like the EpiPen and the
Auvi-Q. However, regardless of any design changes, it is imperative that the device be
incorporated into a smartphone case. While many people forget their EpiPens or choose to not
carry it with them, having their phones on them has become second nature. The proposed
device is not only smaller and more ergonomic than a current EpiPen, but it is also more likely
to be with someone at all times because it is part of their smartphone case.
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